Working… Menu

Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00703378
Recruitment Status : Completed
First Posted : June 23, 2008
Last Update Posted : March 28, 2012
Information provided by (Responsible Party):
Haematology-Oncology, National University Hospital, Singapore